Statements (98)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired by a larger medical device company in 2018
|
| gptkbp:annualVisitors |
Estimated in millions.
|
| gptkbp:awards |
Industry recognition
Received multiple industry awards for innovation. |
| gptkbp:CEO |
gptkb:Dr._David_A._H._Hwang
Dr. Michael J. McGowan |
| gptkbp:clinicalTrials |
Ongoing
Conducts clinical trials for new products. |
| gptkbp:collaborations |
Works with universities for research.
|
| gptkbp:communityEngagement |
Active
|
| gptkbp:communityInvolvement |
Engages in local health initiatives.
|
| gptkbp:competitors |
gptkb:Abbott_Laboratories
gptkb:Boston_Scientific gptkb:Medtronic |
| gptkbp:customerBase |
Hospitals and clinics
Hospitals and healthcare providers. |
| gptkbp:customerSupport |
Dedicated team
Provides 24/7 customer support. |
| gptkbp:employees |
50-100
|
| gptkbp:feedback |
Customer-driven
|
| gptkbp:financials |
Privately held, financials not publicly disclosed.
|
| gptkbp:focus |
Innovative medical solutions
|
| gptkbp:focusArea |
Innovative medical solutions
|
| gptkbp:foundedIn |
2010
|
| gptkbp:founder |
gptkb:Dr._David_A._H._Hwang
Dr. Michael J. McGowan |
| gptkbp:funding |
Venture capital
|
| gptkbp:futurePlans |
Increase market share.
Expand product line. Develop new technologies. Enhance research capabilities. Strengthen global distribution. |
| gptkbp:globalPresence |
Expanding
Operates in multiple countries. |
| gptkbp:hasCompetitors |
gptkb:Johnson_&_Johnson
gptkb:Abbott_Laboratories gptkb:Terumo_Corporation gptkb:Boston_Scientific gptkb:Medtronic |
| gptkbp:headCoach |
Growing
|
| gptkbp:headquarters |
gptkb:San_Antonio,_Texas
|
| https://www.w3.org/2000/01/rdf-schema#label |
CeloNova BioSciences
|
| gptkbp:industry |
Medical Devices
|
| gptkbp:innovation |
Continuous
|
| gptkbp:investmentFocus |
In research
Venture capital firms. |
| gptkbp:isFacilitatedBy |
High standards
|
| gptkbp:localBusiness |
Private
|
| gptkbp:market |
Global
New products annually Launched new stent technology in 2021. |
| gptkbp:marketingStrategy |
Direct outreach
|
| gptkbp:marketSegment |
Focus on innovation and quality.
|
| gptkbp:mission |
Improve patient outcomes
To improve patient outcomes through innovative technology. |
| gptkbp:network |
Industry events
|
| gptkbp:numberOfEmployees |
51-200
|
| gptkbp:partnerships |
Various healthcare institutions
Collaborations with universities Strategic partnerships with tech companies. Collaborates with various hospitals and clinics |
| gptkbp:patentCitation |
Multiple granted
Holds several patents in cardiovascular technology. |
| gptkbp:products |
gptkb:CeloNova_BioCoat
gptkb:CeloNova_BioStent Patient-centered Focuses on user-friendly designs. Biocompatible materials. CeloNova Bioabsorbable Stent Enhanced patient recovery. Long-lasting performance. Minimally invasive technology. Reduced risk of complications. CeloNova_Stent |
| gptkbp:regulatoryCompliance |
Stringent
FDA_approved |
| gptkbp:researchAndDevelopment |
Active
Invests heavily in R&D |
| gptkbp:researchFocus |
Cardiovascular innovations
|
| gptkbp:sells |
Increasing
|
| gptkbp:sisterCity |
Direct sales and distributors.
|
| gptkbp:socialMedia |
Active_on_LinkedIn_and_Twitter.
|
| gptkbp:socialResponsibility |
Health initiatives
|
| gptkbp:specializesIn |
Cardiovascular Devices
|
| gptkbp:strategicGoals |
Long-term success
|
| gptkbp:supplyChain |
Efficient
|
| gptkbp:sustainability |
Commitment to eco-friendly practices
|
| gptkbp:sustainabilityPractices |
Focuses on sustainable manufacturing.
|
| gptkbp:targetMarket |
Cardiologists
|
| gptkbp:technology |
Bioabsorbable stents
|
| gptkbp:training |
Offers extensive training programs.
|
| gptkbp:trainingPrograms |
For healthcare professionals
|
| gptkbp:vision |
To be a leader in the cardiovascular device market.
Leading in cardiovascular technology. Transforming cardiovascular care |
| gptkbp:website |
www.celonovabio.com
|
| gptkbp:youth_development |
Sustainable
|